Vida taps Wood as new CEO, prez

Vida Diagnostics, a developer of quantitative imaging software for the analysis of pulmonary diseases, has appointed Susan A. Wood, PhD, as president and CEO.

Wood succeeds John Garber, and she will focus on the continued development and commercialization of the company’s FDA-cleared pulmonary applications and establishing quantitative pulmonary imaging into routine clinical practice, according to the Iowa City, Iowa-based company.

Wood, who joined Vida’s board in 2008, most recently held the position of executive vice president of marketing and technology at Vital Images, where she was responsible for the development and commercialization of the company’s clinical applications for Toshiba Medical System's Aquilion One CT. Previously, Wood led marketing and new product development at R2 Technology, now part of Hologic.

Around the web

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Trimed Popup
Trimed Popup